<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37569612</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Coronavirus Disease Pathophysiology: Biomarkers, Potential New Remedies, Comorbidities, Long COVID-19, Post Pandemic Epidemiological Surveillance.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12236</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241512236</ELocationID><Abstract><AbstractText>The toughest challenge modern biomedical research ever faced was the rapid understanding of the SARS-CoV-2 physiopathology [...].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubiak</LastName><ForeName>Jacek Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Dynamics and Mechanics of Epithelia Group, Faculty of Medicine, Institute of Genetics and Development of Rennes, University of Rennes, CNRS, UMR 6290, 35000 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Oncology and Innovative Therapies, Department of Oncology, Military Institute of Medicine, 04-141 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloc</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5192-8584</Identifier><AffiliationInfo><Affiliation>Transplant Immunology, The Houston Methodist Research Institute, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The Houston Methodist Hospital, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>10</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37569612</ArticleId><ArticleId IdType="pmc">PMC10419002</ArticleId><ArticleId IdType="doi">10.3390/ijms241512236</ArticleId><ArticleId IdType="pii">ijms241512236</ArticleId></ArticleIdList><ReferenceList><Reference><Citation> [(accessed on 18 July 2023)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Chumakov K., Benn C.S., Aaby P., Kottilil S., Gallo R. Can existing live vaccines prevent COVID-19? Science. 2020;368:1187&#x2013;1188. doi: 10.1126/science.abc4262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc4262</ArticleId><ArticleId IdType="pubmed">32527819</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea M.G., Giamarellos-Bourboulis E.J., Dominguez-Andres J., Curtis N., van Crevel R., van de Veerdonk F.L., Bonten M. Trained Immunity: A Toolfor Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell. 2020;181:969&#x2013;977. doi: 10.1016/j.cell.2020.04.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.042</ArticleId><ArticleId IdType="pmc">PMC7196902</ArticleId><ArticleId IdType="pubmed">32437659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloc M., Ghobrial R.M., Kubiak J.Z. Commentary: Trained immunity and beyond: The not-yet lost chance to win with COVID-19. J. Lung Health Dis. 2020;4:8&#x2013;10. doi: 10.29245/2689-999X/2020/3.1166.</Citation><ArticleIdList><ArticleId IdType="doi">10.29245/2689-999X/2020/3.1166</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapolnik P., Kmiecik W., Mazur A., Czajka H. Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19. Int. J. Mol. Sci. 2023;24:3218. doi: 10.3390/ijms24043218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043218</ArticleId><ArticleId IdType="pmc">PMC9961109</ArticleId><ArticleId IdType="pubmed">36834629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudowska-Sawczuk M., Moniuszko-Malinowska A., P&#x105;czek S., Guziejko K., Chorazy M., Mroczko B. Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2. Int. J.Mol. Sci. 2022;23:11589. doi: 10.3390/ijms231911589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911589</ArticleId><ArticleId IdType="pmc">PMC9569841</ArticleId><ArticleId IdType="pubmed">36232891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Quan L., Chen R., Liu D. Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection. Int. J. Mol. Sci. 2022;23:11692. doi: 10.3390/ijms231911692.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911692</ArticleId><ArticleId IdType="pmc">PMC9570369</ArticleId><ArticleId IdType="pubmed">36232993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutanu A., Manu D., Gabor M.R., Vasies A.M., Andrejkovits A.V., Dobreanu M. Dynamic Evaluation of Natural Killer Cells Subpopulations in COVID-19 Patients. Int. J. Mol. Sci. 2022;23:11875. doi: 10.3390/ijms231911875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911875</ArticleId><ArticleId IdType="pmc">PMC9569797</ArticleId><ArticleId IdType="pubmed">36233174</ArticleId></ArticleIdList></Reference><Reference><Citation>Baena Carstens L., Campos D&#x2019;Amico R., Fernandes de Moura K., Morais de Castro E., Centenaro F., Silva Barbosa G., Vieira Cavalcante da Silva G., Brenny I., Hon&#xf3;rio D&#x2019;Agostini J.C., Hlatchuk E.C., et al. Lung Inflammasome Activation in SARS-CoV-2 Post-Mortem Biopsies. Int. J. Mol. Sci. 2022;23:13033. doi: 10.3390/ijms232113033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232113033</ArticleId><ArticleId IdType="pmc">PMC9659061</ArticleId><ArticleId IdType="pubmed">36361818</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller M., Oberhuber M., Prietl B., Z&#xfc;gner E., Prugger E.-M., Magnes C., Kirsch A.H., Schmaldienst S., Pieber T., Brodmann M., et al. Alterations in the Kynurenine&#x2013;Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis. Int. J. Mol. Sci. 2022;23:14089. doi: 10.3390/ijms232214089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232214089</ArticleId><ArticleId IdType="pmc">PMC9698708</ArticleId><ArticleId IdType="pubmed">36430566</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuli&#x144;ski A. Weak Point of SARS-CoV-2: Human and Viral Ion Channels under External Physical Fields. Int. J. Mol. Sci. 2022;23:15185. doi: 10.3390/ijms232315185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232315185</ArticleId><ArticleId IdType="pmc">PMC9737394</ArticleId><ArticleId IdType="pubmed">36499511</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschi C., Scheim D.E., Bancod A., Militello M., Bideau M.L., Colson P., Fantini J., Scola B.L. SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. Int. J. Mol. Sci. 2022;23:15480. doi: 10.3390/ijms232415480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415480</ArticleId><ArticleId IdType="pmc">PMC9779393</ArticleId><ArticleId IdType="pubmed">36555121</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson A.O., Hultstr&#xf6;m M., Frithiof R., Lipcsey M., Eriksson M.B. Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19. Int. J. Mol. Sci. 2022;23:15687. doi: 10.3390/ijms232415687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415687</ArticleId><ArticleId IdType="pmc">PMC9779236</ArticleId><ArticleId IdType="pubmed">36555328</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufrusine B., Valentinuzzi S., Bibb&#xf2; S., Damiani V., Lanuti P., Pieragostino D., Del Boccio P., D&#x2019;Alessandro E., Rabottini A., Berghella A., et al. Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation. Int. J. Mol. Sci. 2023;24:15. doi: 10.3390/ijms24010015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010015</ArticleId><ArticleId IdType="pmc">PMC9819889</ArticleId><ArticleId IdType="pubmed">36613462</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmakova A.A., Popov V.S., Romanov I.P., Khabibullin N.R., Sabitova N.R., Karpukhina A.A., Kozhevnikova Y.A., Kurilina E.V., Tsokolaeva Z.I., Klimovich P.S., et al. Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19. Int. J. Mol. Sci. 2023;24:1382. doi: 10.3390/ijms24021382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021382</ArticleId><ArticleId IdType="pmc">PMC9867169</ArticleId><ArticleId IdType="pubmed">36674896</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwish S., Liu L.P., Robinson T.O., Tarugu S., Owings A.H., Glover S.C., Alli A.A. COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells. Int. J. Mol. Sci. 2023;24:1654. doi: 10.3390/ijms24021654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021654</ArticleId><ArticleId IdType="pmc">PMC9861961</ArticleId><ArticleId IdType="pubmed">36675169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Cuadrado C., Caro-Espada P.J., Chivite-Lacaba M., Utrero-Rico A., Lozano-Yuste C., Gutierrez-Solis E., Morales E., Sandino-P&#xe9;rez J., Gil-Etayo F.J., Allende-Mart&#xed;nez L., et al. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients. Int. J. Mol. Sci. 2023;24:1712. doi: 10.3390/ijms24021712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021712</ArticleId><ArticleId IdType="pmc">PMC9865754</ArticleId><ArticleId IdType="pubmed">36675231</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;m&#xf6;t&#xf6;r O., Enyedy &#xc9;.A. Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2. Int. J. Mol. Sci. 2023;24:2849. doi: 10.3390/ijms24032849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032849</ArticleId><ArticleId IdType="pmc">PMC9917862</ArticleId><ArticleId IdType="pubmed">36769193</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani F.A., Khan M.F., Ahmad V. Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients. Int. J. Mol. Sci. 2023;24:3562. doi: 10.3390/ijms24043562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043562</ArticleId><ArticleId IdType="pmc">PMC9965082</ArticleId><ArticleId IdType="pubmed">36834974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K., Meglic A., Lapajne L., Logar M., Vidovic Valentincic N., Globocnik Petrovic M., Jaki Mekjavic P. The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging&#x2014;A Prospective Longitudinal Cohort Study. Int. J. Mol. Sci. 2023;24:4032. doi: 10.3390/ijms24044032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24044032</ArticleId><ArticleId IdType="pmc">PMC9966689</ArticleId><ArticleId IdType="pubmed">36835445</ArticleId></ArticleIdList></Reference><Reference><Citation>Denaro M., Ferro E., Barrano G., Meli S., Busacca M., Corallo D., Capici A., Zisa A., Cucuzza L., Gradante S., et al. Monitoring of SARS-CoV-2 Infection in Ragusa Area: Next Generation Sequencing and Serological Analysis. Int. J. Mol. Sci. 2023;24:4742. doi: 10.3390/ijms24054742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054742</ArticleId><ArticleId IdType="pmc">PMC10003428</ArticleId><ArticleId IdType="pubmed">36902172</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini S., Madonna G., Di Gennaro E., Capone F., Bagnara P., Capone M., Sale S., Nicastro C., Atripaldi L., Fiorentino G., et al. New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer. Int. J. Mol. Sci. 2023;24:4922. doi: 10.3390/ijms24054922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054922</ArticleId><ArticleId IdType="pmc">PMC10003544</ArticleId><ArticleId IdType="pubmed">36902351</ArticleId></ArticleIdList></Reference><Reference><Citation>Urazov S., Chernov A., Popov O., Klenkova N., Sushentseva N., Polkovnikova I., Apalko S., Kislyuk K., Pavlovich D., Ivanov A., et al. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections. Int. J. Mol. Sci. 2023;24:5540. doi: 10.3390/ijms24065540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065540</ArticleId><ArticleId IdType="pmc">PMC10059025</ArticleId><ArticleId IdType="pubmed">36982611</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson E.C., Macsai M., Bertrand S., Bertrand D., Nau J. The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline. Int. J. Mol. Sci. 2023;24:5597. doi: 10.3390/ijms24065597.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065597</ArticleId><ArticleId IdType="pmc">PMC10051900</ArticleId><ArticleId IdType="pubmed">36982671</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva E., Atanasov V., Kostandieva R., Tsoneva V., Mitev M., Arabadzhiev G., Yovchev Y., Karamalakova Y., Nikolova G. Direct Application of 3-Maleimido-PROXYL for Proving Hypoalbuminemia in Cases of SARS-CoV-2 Infection: The Potential Diagnostic Method of Determining Albumin Instability and Oxidized Protein Level in Severe COVID-19. Int. J. Mol. Sci. 2023;24:5807. doi: 10.3390/ijms24065807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065807</ArticleId><ArticleId IdType="pmc">PMC10058219</ArticleId><ArticleId IdType="pubmed">36982882</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbiola-Salvador V., Lima de Souza S., Gre&#x161;ner P., Qureshi T., Chen Z. Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection. Int. J. Mol. Sci. 2023;24:6276. doi: 10.3390/ijms24076276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076276</ArticleId><ArticleId IdType="pmc">PMC10093853</ArticleId><ArticleId IdType="pubmed">37047248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinskaya A., Vorobyeva D., Rusakovich G., Maryukhnich E., Anisimova A., Dukhin O., Elizarova A., Ivanova O., Bugrova A., Brzhozovskiy A., et al. Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction. Int. J. Mol. Sci. 2023;24:6523. doi: 10.3390/ijms24076523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076523</ArticleId><ArticleId IdType="pmc">PMC10094800</ArticleId><ArticleId IdType="pubmed">37047497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>